Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy

NCT07493265 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT07493265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07493265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
Lead sponsor
Eisai Inc.
Phase
Phase 2
Overall status
Recruiting
Start date
March 26, 2026
Completion date
March 1, 2027
Enrollment
64 (estimated)
Sites
57

Conditions

As the registry lists them; a condition with its own page is linked.

narcolepsy